Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
SpyGlass DS I - II
Locations
6
United States
Sutter Davis Hospital
Davis, California, United States
UC Davis Health
Sacramento, California, United States
University of Utah Hospital and Clinic
Salt Lake City, Utah, United States
Aspen Woods Clinic
Calgary, Alberta, Canada
Academic Medical Center
Amsterdam-Zuidoost, Netherlands
Rikshospitalet University Hospital
Oslo, Norway
Start Date
December 6, 2018
Primary Completion Date
December 12, 2022
Completion Date
December 12, 2022
Last Updated
January 25, 2023
NCT06026865
NCT01161992
NCT06686810
NCT06037577
NCT05082779
NCT02177136
Lead Sponsor
Boston Scientific Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions